Last reviewed · How we verify

NCT06116955

The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy

Completed Last updated 31 January 2024
What this trial tests

trial testing Midazolam and sufentanil in Bronchoscopy in 424 participants. Completed in 1 January 2024.

Timeline
21 September 2023
Primary endpoint
31 December 2023
1 January 2024

Quick facts

Lead sponsorThe Affiliated Hospital of Qingdao University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment424
Start date21 September 2023
Primary completion31 December 2023
Estimated completion1 January 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The Affiliated Hospital of Qingdao University

Who can join

Adults 18 to 100, any sex, with Bronchoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the feasibility of using balanced propofol sedation for bronchoscopy. And screen out the optimal balanced propofol sedation compatibility plan.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Efficacy and Safety Profile of Balanced Propofol Sedation for Bronchoscopy.
    Wu X, Zhang L, Zhou Z, Qi L, et al · · 2024 · cited 2× · PMID 39691941 · DOI 10.2147/tcrm.s495253

Verify or expand the search:

Other recruiting trials for Bronchoscopy

Currently open trials in the same condition.

Other The Affiliated Hospital of Qingdao University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06116955.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing